We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
-1.04%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$165M
AUM Growth
-$4.08M
Cap. Flow
+$2.01M
Cap. Flow %
1.22%
Top 10 Hldgs %
6.09%
Holding
488
New
53
Increased
73
Reduced
307
Closed
54

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$805K
2
HAL icon
Halliburton
HAL
+$792K
3
CAT icon
Caterpillar
CAT
+$787K
4
STLD icon
Steel Dynamics
STLD
+$775K
5
BKNG icon
Booking.com
BKNG
+$775K

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$1.05M
2
VMC icon
Vulcan Materials
VMC
+$1.01M
3
CSGP icon
CoStar Group
CSGP
+$998K
4
LLY icon
Eli Lilly
LLY
+$967K
5
IR icon
Ingersoll Rand
IR
+$913K

Sector Composition

Rank Sector Weight
1 Healthcare 18.63%
2 Financials 17.26%
3 Technology 14.89%
4 Energy 9.42%
5 Consumer Discretionary 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEGN icon
201
Legend Biotech
LEGN
$3.73B
$296K 0.18%
4,409
-573
-12% -$39.8K
GILD icon
202
Gilead Sciences
GILD
$162B
$295K 0.18%
3,941
-467
-11% -$35.9K
AGIO icon
203
Agios Pharmaceuticals
AGIO
$2.2B
$293K 0.18%
11,823
-1,532
-11% -$40.5K
CEN
204
DELISTED
Center Coast Brookfield MLP & Energy Infrastructure Fund
CEN
$290K 0.18%
+13,699
New +$284K
INCY icon
205
Incyte
INCY
$23.7B
$286K 0.17%
4,951
-11,114
-69% -$701K
BMRN icon
206
BioMarin Pharmaceuticals
BMRN
$11.6B
$285K 0.17%
3,221
-419
-12% -$37.3K
SRPT icon
207
Sarepta Therapeutics
SRPT
$1.68B
$283K 0.17%
2,334
-301
-11% -$34K
ADMA icon
208
ADMA Biologics
ADMA
$1.97B
$280K 0.17%
78,224
-10,111
-11% -$38.9K
HRMY icon
209
Harmony Biosciences
HRMY
$2.08B
$279K 0.17%
8,510
-1,099
-11% -$38.2K
FOLD
210
DELISTED
Amicus Therapeutics
FOLD
$278K 0.17%
22,877
-2,959
-11% -$38.2K
IMCR icon
211
Immunocore
IMCR
$1.72B
$273K 0.17%
5,265
-684
-11% -$40.5K
DCPH
212
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$273K 0.17%
21,460
-2,773
-11% -$38.3K
IMGN
213
DELISTED
Immunogen Inc
IMGN
$273K 0.17%
17,174
-2,218
-11% -$36.9K
ALNY icon
214
Alnylam Pharmaceuticals
ALNY
$37.2B
$271K 0.16%
1,533
-198
-11% -$37.8K
BCRX icon
215
BioCryst Pharmaceuticals
BCRX
$2.43B
$271K 0.16%
38,321
-4,957
-11% -$35.6K
ZLAB icon
216
Zai Lab
ZLAB
$2.1B
$267K 0.16%
10,998
-1,425
-11% -$37.9K
IRWD icon
217
Ironwood Pharmaceuticals
IRWD
$644M
$265K 0.16%
27,538
-3,559
-11% -$34.9K
AXSM icon
218
Axsome Therapeutics
AXSM
$12.3B
$263K 0.16%
3,762
-485
-11% -$36.3K
ACAD icon
219
Acadia Pharmaceuticals
ACAD
$4.35B
$263K 0.16%
12,605
-1,630
-11% -$44.3K
ONC
220
BeOne Medicines Ltd
ONC
$33.8B
$262K 0.16%
1,459
-192
-12% -$38K
BIIB icon
221
Biogen
BIIB
$29.5B
$261K 0.16%
1,016
-129
-11% -$34.5K
BPMC
222
DELISTED
Blueprint Medicines
BPMC
$260K 0.16%
5,179
-669
-11% -$35.7K
VRN
223
DELISTED
Veren
VRN
$254K 0.15%
30,645
-2,406
-7% -$19.2K
TBPH icon
224
Theravance Biopharma
TBPH
$874M
$252K 0.15%
29,232
-3,777
-11% -$36.5K
SXC icon
225
SunCoke Energy
SXC
$765M
$252K 0.15%
24,853
-685
-3% -$6.2K
7 8
9
10 11

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, Virtus ETF Advisers held 488 positions worth $165M, down 2.4% from $169M the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Virtus ETF Advisers's Q3 2023 filing shows 53 new, 73 increased, 307 reduced and 54 closed positions. Its largest new stake was Alphabet (Google) Class A: 6,222 shares worth $814K. The largest sale was Netflix, an estimated $1.05M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 28% a quarter earlier, followed by Financials and Technology.

  • Virtus ETF Advisers's largest Q3 2023 buy was Alphabet (Google) Class A: 6,222 shares worth $814K.
  • Virtus ETF Advisers added most to Coterra Energy in Q3 2023, an estimated $732K increase.
  • Virtus ETF Advisers's biggest Q3 2023 reduction was Incyte, cutting an estimated $701K.
  • Virtus ETF Advisers fully exited Netflix in Q3 2023, selling an estimated $1.05M.
  • Virtus ETF Advisers's ten largest holdings make up 6.1% of its $165M portfolio in Q3 2023.
  • Virtus ETF Advisers opened 53 new positions and closed 54 in Q3 2023.
  • Virtus ETF Advisers's portfolio value fell 2.4% quarter-over-quarter to $165M.

Based on Virtus ETF Advisers's 13F filing for Q3 2023, filed 7 Nov 2023.